Can	can	O	O
angiogenesis	angiogenesis	O	O
be	be	O	O
a	a	O	O
target	target	O	O
of	of	O	O
treatment	treatment	O	O
for	for	O	O
ribavirin	ribavirin	S_chemicals	O
associated	associated	O	O
hemolytic	hemolytic	O	O
anemia?BACKGROUND/AIMS	anemia?background/aims	O	O
:	:	O	O
Recently	recently	O	O
ribavirin	ribavirin	S_chemicals	O
has	has	O	O
been	been	O	O
found	found	O	O
to	to	O	O
inhibit	inhibit	O	O
angiogenesis	angiogenesis	O	O
and	and	O	O
a	a	O	O
number	number	O	O
of	of	O	O
angiogenesis	angiogenesis	B_chemicals	O
inhibitors	inhibitors	I_chemicals	O
such	such	O	O
as	as	O	O
sunitinib	sunitinib	S_chemicals	O
and	and	O	O
sorafenib	sorafenib	O	O
have	have	O	O
been	been	O	O
found	found	O	O
to	to	O	O
cause	cause	O	O
acute	acute	O	O
hemolysis	hemolysis	O	S_disease
.	.	O	O

We	we	O	O
aimed	aimed	O	O
to	to	O	O
investigate	investigate	O	O
whether	whether	O	O
there	there	O	O
is	is	O	O
a	a	O	O
relation	relation	O	O
between	between	O	O
hemoglobin	hemoglobin	S_chemicals	O
,	,	O	O
haptoglobin	haptoglobin	S_chemicals	O
and	and	O	O
angiogenesis	angiogenesis	O	O
soluble	soluble	O	O
markers	markers	O	O
which	which	O	O
are	are	O	O
modifiable	modifiable	O	O
and	and	O	O
can	can	O	O
help	help	O	O
in	in	O	O
developing	developing	O	O
strategies	strategies	O	O
against	against	O	O
anemia	anemia	O	S_disease
.	.	O	O

METHODS	methods	O	O
:	:	O	O
Fourteen	fourteen	O	O
patients	patients	O	O
chronically	chronically	O	O
infected	infected	O	O
with	with	O	O
hepatitis	hepatitis	O	B_disease
C	c	O	I_disease
virus	virus	O	O
were	were	O	O
treated	treated	O	O
by	by	O	O
pegylated	pegylated	O	O
interferon	interferon	B_chemicals	O
alpha	alpha	I_chemicals	O
2a	2a	O	O
and	and	O	O
ribavirin	ribavirin	S_chemicals	O
.	.	O	O

Serum	serum	O	O
hemoglobin	hemoglobin	S_chemicals	O
,	,	O	O
haptoglobin	haptoglobin	S_chemicals	O
and	and	O	O
angiogenesis	angiogenesis	O	O
markers	markers	O	O
of	of	O	O
vascular	vascular	B_chemicals	O
endothelial	endothelial	B_chemicals	O
growth	growth	B_chemicals	O
factor	factor	I_chemicals	O
and	and	O	O
angiopoetin-2	angiopoetin-2	O	O
were	were	O	O
investigated	investigated	O	O
before	before	O	O
and	and	O	O
after	after	O	O
therapy	therapy	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
We	we	O	O
observed	observed	O	O
a	a	O	O
significant	significant	O	O
decrease	decrease	O	O
in	in	O	O
haptoglobin	haptoglobin	S_chemicals	O
levels	levels	O	O
at	at	O	O
the	the	O	O
end	end	O	O
of	of	O	O
the	the	O	O
treatment	treatment	O	O
period	period	O	O
.	.	O	O

Hemoglobin	hemoglobin	S_chemicals	O
levels	levels	O	O
also	also	O	O
decreased	decreased	O	O
but	but	O	O
insignificantly	insignificantly	O	O
by	by	O	O
treatment	treatment	O	O
.	.	O	O

In	in	O	O
contrast	contrast	O	O
with	with	O	O
the	the	O	O
literature	literature	O	O
,	,	O	O
serum	serum	O	O
levels	levels	O	O
of	of	O	O
angiogenesis	angiogenesis	O	O
factors	factors	O	O
did	did	O	O
not	not	O	O
change	change	O	O
significantly	significantly	O	O
by	by	O	O
pegylated	pegylated	O	O
interferon	interferon	S_chemicals	O
and	and	O	O
ribavirin	ribavirin	S_chemicals	O
therapy	therapy	O	O
.	.	O	O

We	we	O	O
found	found	O	O
no	no	O	O
correlation	correlation	O	O
of	of	O	O
angiogenesis	angiogenesis	O	O
soluble	soluble	O	O
markers	markers	O	O
with	with	O	O
either	either	O	O
hemoglobin	hemoglobin	S_chemicals	O
or	or	O	O
haptoglobin	haptoglobin	S_chemicals	O
.	.	O	O

CONCLUSION	conclusion	O	O
:	:	O	O
This	this	O	O
is	is	O	O
the	the	O	O
first	first	O	O
study	study	O	O
in	in	O	O
the	the	O	O
literature	literature	O	O
investigating	investigating	O	O
a	a	O	O
link	link	O	O
between	between	O	O
angiogenesis	angiogenesis	O	O
soluble	soluble	O	O
markers	markers	O	O
and	and	O	O
ribavirin	ribavirin	S_chemicals	O
induced	induced	O	O
anemia	anemia	O	S_disease
in	in	O	O
patients	patients	O	O
with	with	O	O
hepatitis	hepatitis	O	B_disease
C	c	O	I_disease
and	and	O	O
we	we	O	O
could	could	O	O
not	not	O	O
find	find	O	O
any	any	O	O
relation	relation	O	O
.	.	O	O

Future	future	O	O
research	research	O	O
with	with	O	O
larger	larger	O	O
number	number	O	O
of	of	O	O
patients	patients	O	O
is	is	O	O
needed	needed	O	O
to	to	O	O
find	find	O	O
out	out	O	O
modifiable	modifiable	O	O
factors	factors	O	O
that	that	O	O
will	will	O	O
improve	improve	O	O
the	the	O	O
safety	safety	O	O
of	of	O	O
ribavirin	ribavirin	S_chemicals	O
therapy	therapy	O	O
.	.	O	O

